Cullinan Oncology Inc. News
Latest updates and market news for CGEM
7 news
Mar 10 - Mar 16, 2026
Page 1
PR Newswire
CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight
📈
AI Sentiment
Highly Positive
9/10
MT Newswires
Wedbush Adjusts Price Target on Cullinan Therapeutics to $36 From $34, Maintains Outperform Rating
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
Cullinan Therapeutics Q4 Loss Widens
Associated Press Finance
Cullinan Therapeutics: Q4 Earnings Snapshot
Share this news page